Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01811498
Title Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors North Shore Long Island Jewish Health System
Age Groups: adult
Covered Countries USA

No variant requirements are available.